The ITCH (Ab-420) Antibody is synthesized against a phosphorylated peptide derived from human ITCH, specifically around tyrosine 420 (F-I-Y(p)-G-N) . This phosphosite-specific design ensures precise recognition of ITCH in its active state, making it suitable for studying post-translational modifications (PTMs) in cellular pathways .
Source: The antibody is produced in rabbits via peptide immunization, followed by affinity purification to enhance specificity .
Cross-reactivity: It exhibits reactivity with human and mouse ITCH proteins, enabling cross-species research applications .
Applications: Validated for Western blot (WB) and enzyme-linked immunosorbent assay (ELISA), with recommended dilutions of 1:500–1:3000 (WB) and 1:2000–1:10000 (ELISA) .
| Assay | Recommended Dilution | Species |
|---|---|---|
| WB | 1:500–1:3000 | Human, Mouse |
| ELISA | 1:2000–1:10000 | Human, Mouse |
ITCH (E3 ubiquitin-protein ligase Itchy) belongs to the Nedd4 family of HECT domain ligases, mediating ubiquitination of target proteins for lysosomal degradation . Its roles include:
Immune regulation: Promoting T-cell activation and cytokine signaling .
Oncogenic regulation: Modulating receptor turnover in cancer cells .
Viral interactions: Associating with Epstein-Barr virus LMP2A to suppress B-cell signaling .
| Source | Format | Reactivity | Applications |
|---|---|---|---|
| Assay Genie | Rabbit IgG (Ab-420) | Human, Mouse | WB, ELISA |
| Cusabio | Recombinant Monoclonal | Human | WB, ELISA |
| Boster Bio | Rabbit IgG (A00195) | Human, Mouse, Rat | WB, IHC, ELISA |
Cancer studies: ITCH antibodies are used to investigate receptor degradation in tumor cells, such as CXCR4 in invasive ductal carcinoma .
Autoimmune diseases: ITCH’s role in T-cell regulation makes it a target for therapies in multisystem autoimmune disorders .
Neurological research: Detection of ITCH in mouse brain lysates highlights its function in neuronal protein turnover .
Western blot analysis using the ITCH (Ab-420) Antibody demonstrates:
ITCH (Ab-420) Antibody is a rabbit polyclonal antibody that detects endogenous levels of total ITCH protein, a critical E3 ubiquitin-protein ligase in cellular signaling pathways. This antibody specifically recognizes the region surrounding the tyrosine 420 phosphorylation site (F-I-Y(p)-G-N) within human ITCH protein . The immunogen used to generate this antibody is a synthesized non-phosphopeptide derived from this specific region, enabling detection of the ITCH protein regardless of its phosphorylation status at this site . The antibody demonstrates reactivity to both human and mouse ITCH proteins, making it suitable for comparative studies across these species .
Based on empirical validation data, ITCH (Ab-420) Antibody has been confirmed effective for the following applications:
The antibody has been validated in Western blot analysis of extracts from mouse brain cells as well as HepG2 human liver cancer cell lines, demonstrating reliable detection of the target protein in diverse tissue and cell types . It's important to note that each new experimental system may require optimization of antibody concentration and assay conditions for optimal results.
For unconjugated ITCH (Ab-420) Antibody, optimal storage is at -20°C in its formulation buffer consisting of rabbit IgG in phosphate buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, containing 150mM NaCl, 0.02% sodium azide and 50% glycerol . This formulation provides stability while preventing microbial contamination and freeze-thaw damage.
For conjugated versions of the antibody, storage recommendations vary by conjugate type. Fluorophore-conjugated antibodies (such as AF350, AF488, AF555) should generally be stored at 4°C in the dark for up to 6 months to prevent photobleaching and maintain signal intensity . Always refer to specific product documentation for conjugate-specific storage guidance.
A multi-faceted validation approach is recommended:
Peptide competition assay: As demonstrated in validation data, pre-incubating the antibody with the synthesized peptide immunogen effectively blocks specific binding in Western blot analysis of HepG2 cells . This approach confirms epitope-specific binding.
Positive and negative control samples: Include known ITCH-expressing tissues (such as mouse brain) as positive controls and consider ITCH-knockout or knockdown samples as negative controls when available.
Size verification: The ITCH protein has a calculated molecular weight of approximately 103 kDa . Verify that the detected band appears at the expected molecular weight.
Cross-species comparison: The validated reactivity to both human and mouse samples provides an opportunity for specificity verification across species with conserved epitopes.
When working with complex tissue samples such as brain tissue:
Sample preparation optimization: Thoroughly homogenize tissues in appropriate lysis buffers containing protease and phosphatase inhibitors to prevent degradation.
Blocking optimization: Use 5% non-fat dry milk or BSA in TBST for Western blot applications to minimize background signal.
Antibody dilution titration: Begin with the manufacturer's recommended range (1:500-1:3000 for WB) but perform a dilution series to determine optimal signal-to-noise ratio for your specific sample type.
Incubation conditions: For brain tissue samples, overnight primary antibody incubation at 4°C often yields better results than shorter incubations at room temperature.
Detection system selection: Choose detection systems compatible with the expected abundance of ITCH in your samples. Enhanced chemiluminescence (ECL) systems work well for moderate abundance proteins, while more sensitive detection methods may be required for low-abundance samples.
ITCH (Ab-420) Antibody is available in multiple conjugated forms with distinct spectral properties to support various experimental platforms:
| Conjugate Type | Excitation (nm) | Emission (nm) | Recommended Applications |
|---|---|---|---|
| AF350 | 346 | 442 | Flow cytometry, microscopy with UV excitation |
| AF488 | 493 | 519 | Flow cytometry, standard fluorescence microscopy |
| AF555 | 555 | 565 | Multiplex imaging with green fluorophores |
| AF594 | 591 | 614 | Confocal microscopy |
| AF647 | 651 | 667 | Flow cytometry, far-red imaging |
| AF680 | 679 | 702 | Near-infrared imaging systems |
| AF750 | 749 | 775 | In vivo imaging applications |
When using conjugated antibodies:
Protect from light during all handling steps
Consider spectral overlap when designing multiplex experiments
Include appropriate single-stained controls for compensation in flow cytometry
Titrate antibody concentration for optimal signal-to-noise ratio
If experiencing non-specific binding or high background:
Increase blocking stringency: Extend blocking time to 2 hours or switch blocking reagent (BSA vs. milk) based on your detection system.
Optimize antibody concentration: Further dilute the antibody beyond the recommended range if signal-to-noise ratio is poor.
Add detergent: Increase Tween-20 concentration in wash buffers to 0.1-0.3% to reduce hydrophobic interactions.
Pre-absorb the antibody: For tissues with known cross-reactivity issues, consider pre-absorbing the antibody with tissue lysate from a negative control sample.
Peptide competition: Use the immunizing peptide as a competitive inhibitor to distinguish between specific and non-specific binding.
For reliable quantitative analysis:
Loading control selection: Choose appropriate loading controls based on your experimental system (β-actin, GAPDH, or total protein staining).
Linear dynamic range determination: Perform a sample dilution series to ensure quantification occurs within the linear detection range of both the antibody and detection system.
Normalization strategy: For phosphorylation studies, normalize phospho-specific signals to total ITCH protein levels rather than just to loading controls.
Technical replicates: Include at least three technical replicates for statistical validity.
Image acquisition parameters: Use identical exposure settings when comparing samples across different blots or immunofluorescence images.
ITCH functions as an E3 ubiquitin ligase involved in protein degradation pathways. To study this function:
Co-immunoprecipitation studies: Use ITCH (Ab-420) Antibody to pull down ITCH complexes and analyze associated proteins to identify novel substrates.
Ubiquitination assays: Combine with anti-ubiquitin antibodies in Western blot analyses to detect ubiquitinated substrates after ITCH immunoprecipitation.
Inhibitor studies: Examine changes in ITCH-substrate interactions following treatment with proteasome inhibitors (MG132) or deubiquitinase inhibitors.
Phosphorylation impact: Since the antibody targets a region near Tyr420, it can be used alongside phospho-specific antibodies to determine how phosphorylation affects ITCH's ubiquitin ligase activity.
Degradation kinetics: Track substrate protein levels over time following ITCH activation or inhibition to characterize degradation kinetics.
To investigate protein-protein interactions:
Proximity ligation assay (PLA): Combine ITCH (Ab-420) Antibody with antibodies against suspected binding partners to visualize and quantify interactions in situ.
FRET analysis: Use fluorophore-conjugated versions of ITCH (Ab-420) Antibody in combination with differently-labeled partner antibodies to study interaction dynamics in living cells.
Pull-down confirmation: Follow up on observed interactions with reciprocal immunoprecipitation using both ITCH (Ab-420) Antibody and antibodies against binding partners.
Domain mapping: Combine with deletion mutant studies to identify specific interaction domains.
Stimulus-response experiments: Monitor how interactions change in response to cellular stressors, signaling activators, or inhibitors.
When selecting between different ITCH antibodies:
Epitope accessibility: The Ab-420 antibody targets a region around tyrosine 420, which may have different accessibility depending on protein conformation and interaction partners compared to antibodies targeting N-terminal or C-terminal epitopes.
Post-translational modification sensitivity: Unlike phospho-specific antibodies, ITCH (Ab-420) Antibody detects total ITCH protein regardless of phosphorylation status, making it suitable for normalization in phosphorylation studies.
Cross-reactivity profile: The specificity for human and mouse ITCH proteins makes this antibody suitable for comparative studies across these species, but researchers working with other model organisms should verify cross-reactivity.
Application versatility: The validated applications (WB, ELISA) may differ from other epitope-targeting antibodies that might be validated for additional applications like immunohistochemistry or immunofluorescence.
Isoform detection: Consider whether the targeted epitope is present in all known ITCH isoforms relevant to your research question.
For robust experimental design:
Technical validation controls:
Primary antibody omission control
Isotype control (rabbit IgG at equivalent concentration)
Peptide competition control using the immunizing peptide
Biological controls:
Quantification controls:
Standard curve for quantitative applications
Loading controls appropriate to your experimental system
Replicate samples for statistical analysis